Trial Profile
Non-Interventional Study of NovoSeven Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Eptacog alfa (Primary)
- Indications Haemophilia A; Haemophilia B
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 16 Apr 2015 New trial record